AR003014A1 - Tableta masticable con efecto efervescente - Google Patents

Tableta masticable con efecto efervescente

Info

Publication number
AR003014A1
AR003014A1 ARP960103712A AR10371296A AR003014A1 AR 003014 A1 AR003014 A1 AR 003014A1 AR P960103712 A ARP960103712 A AR P960103712A AR 10371296 A AR10371296 A AR 10371296A AR 003014 A1 AR003014 A1 AR 003014A1
Authority
AR
Argentina
Prior art keywords
chewable tablet
effervescent
weight
effervescent effect
effect
Prior art date
Application number
ARP960103712A
Other languages
English (en)
Inventor
Gerhard Dr Gergely
Original Assignee
Gergely Gerhard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gergely Gerhard filed Critical Gergely Gerhard
Publication of AR003014A1 publication Critical patent/AR003014A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Tableta masticable con efecto efervescente y un peso por tableta menor que 3 g, y que contiene por lo menos una substancia farmacéutica activa, 15 hasta50% por peso de una base efervescente de un ácido orgánico comestible y un carbonato y/obic arbonato alcalino y/o alcalinotérreo, así como 30 hasta 85%por peso de una substancia de relleno soluble, caracterizada por el hecho de que las partículas de ácido y/o de carbonato de la base efervescente estánrevestidas con un hidrocoloidede pre ferentemente fácil o rápida solubilidad.
ARP960103712A 1995-07-31 1996-07-24 Tableta masticable con efecto efervescente AR003014A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH223095 1995-07-31

Publications (1)

Publication Number Publication Date
AR003014A1 true AR003014A1 (es) 1998-05-27

Family

ID=4228915

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP960103712A AR003014A1 (es) 1995-07-31 1996-07-24 Tableta masticable con efecto efervescente

Country Status (11)

Country Link
US (1) US5869095A (es)
EP (1) EP0804171B1 (es)
JP (1) JPH11509854A (es)
CN (1) CN1192137A (es)
AR (1) AR003014A1 (es)
AT (1) ATE188376T1 (es)
AU (1) AU6734096A (es)
BR (1) BR9611815A (es)
DE (1) DE59604114D1 (es)
ES (1) ES2142601T3 (es)
WO (1) WO1997004754A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804165A (en) * 1996-07-24 1998-09-08 Arnold; Michael J. Antiplaque oral composition
PL197989B1 (pl) * 1997-12-19 2008-05-30 Smithkline Beecham Corp Sposób wytwarzania szybko rozpraszających się tabletek do podawania doustnego, szybko rozpraszający się preparat farmaceutyczny w postaci tabletek i szybko rozpraszająca się, farmaceutycznie dopuszczalna, tabletka do podawania doustnego
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
US7488496B2 (en) 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
US7982008B2 (en) 2002-11-27 2011-07-19 David Bar-Or Treatment of diseases and conditions mediated by increased phosphorylation
US20040223921A1 (en) * 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
AU2004275821A1 (en) * 2003-09-25 2005-04-07 Dmi Biosciences Inc. Methods and products which utilize N-acyl-L-aspartic acid
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
US20060045855A1 (en) * 2004-09-02 2006-03-02 Sasson J A Oral composition for reducing plaque and microbial infections and whitening teeth
BRPI0610780A2 (pt) * 2005-04-22 2016-09-06 Teva Pharma formulação farmacéutica em tablete desintegrante, e, métodos para tratar um paciente em necessidade de tratamento com olanzapina, e para produzir a formulação farmacêutica em tablete
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
WO2007144902A1 (en) * 2006-06-12 2007-12-21 Jubliant Organosys Limited Chewable bilayer tablet formulation
CN101829333B (zh) * 2010-05-27 2012-01-25 上海华茂药业有限公司 一种口腔崩解片的多功能辅料及其制备方法
EP2441436A1 (de) * 2010-10-13 2012-04-18 Fresenius Medical Care Deutschland GmbH Phosphatbinderformulierung zur einfachen Einnahme
CN104363897A (zh) 2012-06-12 2015-02-18 宝洁公司 泡腾剂型
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
FR3003135B1 (fr) * 2013-03-12 2020-10-02 Syral Belgium Nv Procede pour ameliorer les proprietes organoleptiques de gomme a macher sans sucres a base de sorbitol
PL3174521T3 (pl) 2014-07-31 2019-02-28 Pharmathen S.A. Tabletka do żucia dla pacjentów pediatrycznych zawierająca środek przeciwwirusowy i sposób jej wytwarzania
US20200138061A1 (en) * 2018-10-26 2020-05-07 Shoreditch-Son Co., Ltd. Compact-pods of nutrients that dissolve in liquid solutions and manufacturing methods thereof
JP2020103185A (ja) * 2018-12-27 2020-07-09 花王株式会社 密封容器入り発泡性経口錠剤
CN114041549B (zh) * 2021-11-29 2024-02-20 青岛博恩高科生物技术有限公司 一种电解质泡腾粉的制备方法及电解质泡腾粉

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
CH677606A5 (es) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
CA2023493C (en) * 1989-08-31 2000-01-04 Masami Moroi Composition for foaming preparation
ES2097155T3 (es) * 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
ES2079743T3 (es) * 1991-07-01 1996-01-16 Gergely Gerhard Tableta para chupar o masticar.

Also Published As

Publication number Publication date
CN1192137A (zh) 1998-09-02
ES2142601T3 (es) 2000-04-16
DE59604114D1 (de) 2000-02-10
EP0804171B1 (de) 2000-01-05
JPH11509854A (ja) 1999-08-31
EP0804171A1 (de) 1997-11-05
ATE188376T1 (de) 2000-01-15
US5869095A (en) 1999-02-09
BR9611815A (pt) 1999-10-13
AU6734096A (en) 1997-02-26
WO1997004754A1 (de) 1997-02-13

Similar Documents

Publication Publication Date Title
AR003014A1 (es) Tableta masticable con efecto efervescente
ES2079743T3 (es) Tableta para chupar o masticar.
ES2058411T3 (es) Sustancia fr 901228 y su preparacion.
UA66847C2 (uk) Тверда швидкорозчинна композиція селегіліну та спосіб її одержання
TR199500826A2 (tr) Multipl ünite tablet doz formu 2.
JPS643193A (en) Cell and tissue reparative agent
YU23599A (sh) Stabilizovani antihistaminski sirup
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
ES2110212T3 (es) Composicion farmaceutica efervescente que contiene ibuprofeno y su procedimiento de preparacion.
ES2136157T3 (es) Producto granular o comprimido que contiene un sistema efervescente y una sustancia farmaceutica activa, asi como un procedimiento para su preparacion.
AR018828A1 (es) Formulaciones efervescentes solidas de rapida desintegracion para administracion oral.
ATE62419T1 (de) Pharmazeutische zubereitungen, die ester oder amide als wirkstoffe enthalten.
UY24308A1 (es) Tabletas exentas de aglutinante que contienen tramadol o una sal de tramadol, para administracion oral
EA199900102A1 (ru) Таблетка малеата тримебутина, покрытая оболочкой
KR920002155A (ko) 슈크랄페이트(Sucralfate) 저작성 타블렛
CA2008509A1 (en) Stabilizing System for Solid Dosage Forms
DE59001121D1 (en) Antacidatabletten.
IE42774L (en) Composition containing organic dicarbonates
ES2142537T3 (es) Esteres no saturados.
DE69602208D1 (de) Stabilisierte pharmazeutische zusammensetzungen enthaltend dobutamine
DE69921832D1 (de) Pharmazeutische zusammensetzungen mit antitumoraler wirkung auf basis von carboplatin
CA2409845A1 (en) Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
ES8303915A1 (es) "procedimiento para la preparacion de comprimidos a base del antibiotico fosfomicina".
KR880008809A (ko) 안정화된 중아황산염 메나디온 제제 및 이들의 제조
CO4700436A1 (es) Formulaciones orales de ibuprofeno s(+)-